Pupil signs of sympathetic autonomic neuropathy in patients with type 1 diabetes

Diabetes Care

Volumn 25, Issue 9, 2002, Pages 1545-1550

  Pittasch, Daniel ^a   Lobmann, Ralf ^a   Behrens Baumann, Wolfgang ^a   Lehnert, Hendrik ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; COCAINE; EYE DROPS; HEMOGLOBIN A1C; PHOLEDRINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; LOCAL ANESTHETIC AGENT; METHAMPHETAMINE; MYDRIATIC AGENT;

ADRENERGIC SYSTEM; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DENERVATION; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAOCULAR PRESSURE; PERIPHERAL NEUROPATHY; PUPIL; SENSORIMOTOR NEUROPATHY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VISUAL ACUITY; ADULT; DRUG EFFECT; FEMALE; MALE; PUPIL DISEASE; PUPIL REFLEX;

ADULT; ANESTHETICS, LOCAL; AUTONOMIC NERVOUS SYSTEM DISEASES; COCAINE; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; METHAMPHETAMINE; MYDRIATICS; PUPIL DISORDERS; REFLEX, PUPILLARY; SYMPATHOMIMETICS;

EID: 0036728275     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.9.1545     Document Type: Article

References (26)

1. The DCCT Study Group: Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 432:381-389, 2000
2. Donaghue KC: Autonomic neuropathy: diagnosis and impact on health in adolescents with diabetes (Review Article). Horm Res 50:33-37, 1998
3. McNally PG, Lawrence IG, Panerai RB, Weston PJ, Thurston H: Sudden death in type-1 diabetes (Review Article). Diab Obes Metabol 1:151-158, 1999
4. Ziegler D, Gries FA, Spūler M, Lessmann F, The DiaCAN Multicenter Study Group: the epidemiology of diabetic neuropathy (Review Article). Diabet Med 10:82-86, 1993
5. Jude EB, Ryan B, O'Leary BM, Gibson JM, Dodson PM: Pupillary dilatation and driving in diabetic patients. Diabet Med 15:143-147, 1998
6. Zaczek A, Zetterstrom C: Cataract surgery and pupil size in patients with diabetes mellitus. Acta Ophthalmol Scand 75:429-432, 1997
7. Emanuele NV, Emanuele MA: Diabetic neuropathy: therapies for peripheral and autonomic symptoms. Geriatrics 52:40-49, 1997
8. Karavanaki K, Davies AG, Hunt LP, Morgan MH, Baum JD: Pupil size in diabetes. Arch Dis Child 71:511-515, 1994
9. Piha SJ, Halonen JP: Infrared pupillometry in the assessment of autonomic function. Diabetes Res Clin Pract 26 1:61-66, 1994
10. Levy DM, Rowley DA, Abraham RR: Portable infrared pupillometry using Pupil-scan: relation to somatic and autonomic nerve function in diabetes mellitus. Clin Auton Res 2:335-341, 1992
11. Vandertop WP, deVries WB, Notermans NC, Tulleken CA, Gispen WH: Beneficial effect of an ACTH4-9 analogue on experimentally induced diabetic autonomic neuropathy in the eye of the rat under general anaesthesia. J Auton Nerv Syst 51:49-57, 1995
12. Sampo JP, Halonen JP: Infrared pupillometry in the assessment of autonomic function. Diabetes Res Clin Pract 26:61-66, 1994
13. Cahill M, Eustace P, de Jesus V: pupillary autonomic denervation with increasing duration of diabetes mellitus. Br J Ophthalmol 85:1225-1230, 2001
14. Loewenfeld IE: The Pupil: Anatomy, Physiology and Clinical Applications. Vol. I. 1st ed. Detroit, MI, Wayne State University Press, 1993
15. Wilhelm H, Wilhelm B, Kriegbaum C: Interaction of the indirectly acting topical sympathomimetics cocaine and pholedrine. Ger J Ophthalmol 5:168-170, 1996
16. Ziegler D, Dannehl K, Spūler M, Mühlen H, Gries FA: Prevalence of cardiovascular autonomic nerve dysfunction assessed by spectral analysis and standard tests of heart-rate variation in newly diagnosed IDDM patients. Diabetes Care 15:908-911, 1992
17. Ziegler D, Hanefeld M, Ruhnau KJ, Meffiner HP, Lobisch M, Schijtte K, Gries FA, The ALADIN Study Group: treatment of symptomatic diabetic peripheral neuropathy with the antioxidant a-lipoic acid: a 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 38:1425-1433, 1995
18. Lanting P, Bos JE, Aartsen J, Schuman L, Reichert-Thoen J, Heimans JJ: Assessment of pupillary light reflex latency and darkness adapted pupil size in control subjects and in diabetic patients with and without cardiovascular autonomic neuropathy. J Neurol Neurosurg Psychiatry 53:912-914, 1990
19. Kuroda N, Taniguchi H, Baba S, Yamamoto M: Relationship between age and autonomic neuropathy in diabetes mellitus. Diabetes Res Clin Pract 9:49-53, 1990
20. Karachaliou F, Karavanaki K, Greenwood R, Baum JD: Consistency of pupillary abnormality in children and adolescents with diabetes. Diabet Med 14:849-853, 1997
21. Alio J, Hernandez I, Millan A, Sanchez J: Pupil responsiveness in diabetes mellitus. Ann Ophthalmol 21:132-137, 1989
22. Isotani H, Fukumoto Y, Kitaoka H, Furukawa K, Ohsawa N, Utsumi T: Oval pupil in patients with diabetes mellitus: examination by measurement of the dark-adapted pupillary area and pupillary light reflex. Diabetes Res Clin Pract 29:43-48, 1995
23. Hreidarsson AB: The pupil of the eye in diabetes mellitus, an indicator of autonomic nervous dysfunction. Dan Med Bull 39:400-408, 1992
24. Lanting P, Strijers RL, Bos JE, Faes TJ, Heimans JJ: The cause of increased light reflex latencies in diabetic patients: the relationship between pupillary light reflex and visual evoked potential latencies. Electroencephalogr Clin Neurophysiol 78:111-115, 1991
25. Bravenboer B, Hendriksen PH, Oey LP, Gipsen WH, van Huffelen AC, Erkelens DW: Is the corrected QT interval a reliable indicator of the severity of diabetic autonomic neuropathy? Diabetes Care 16:1249-1253, 1993
26. Santiago JV: Lessons from the Diabetes Control and Complications Trial (Review Article). Diabetes 42:1549-1554, 1993